The handling Editor makes the final decision on each manuscript and we strongly ensuring that we keep the editorial decision without the interference of personal, political, or financial interests.
The journals published by Pars biomedical followed the indications provided by the Committee on Publication Ethics (COPE). The Journal also follows the guidelines mentioned in the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals issued by the International Committee of Medical Journal Editors (ICMJE).
Any form of plagiarism will not be tolerated. If a serious evidence of plagiarism was detected by the editorial team or reviewers in any stage of the article process it be can lead to the rejection of the article. But, if only content plagiarism with a tolerable rate (5-30% plagiarism) was detected, the author(s) may ask to revise their content.
Editorial team will consider retracting a publication if there is clear evidence of unreliable data or findings, plagiarism, redundancy or duplicate publication.
You will receive an email notification when your proof is ready for review in PDF. It is the authors’ responsibility to check that all the text and data as contained in the page proofs are correct and suitable for publication. We request that authors pay particular attention to the author’s names and affiliations since no changes can be made after the publication. The proofs must be returned by the deadline to ensure that the journal can be published on time.
The corresponding author is responsible to confirm that all of the listed authors have read and approved the final version of the submitted manuscript. Also, the corresponding author should ensure that the listed authors have made a substantive contribution to the article. The authors’ contributions must be declared in the “Authors’ contributions” section. All contributors who did not meet the criteria for authorship should be listed in the “Acknowledgements” section.
Please note that authors do not permit changing the authorship after acceptance of a manuscript. Any change in authorship after initial submission must be provided by sending a letter to the editorial office described celery the reason(s) of any alterations and signed confirmation of all authors. The editorial office may ask authors to confirm their responses directly via email.
All sources of funding and the role of the sponsor(s) for the research should be declared under a separate heading entitled “Funding”.
Conflicts of interest
Authors must fully declare any existing or potential conflicts of interest of a financial, personal, or any other nature that could affect or bias their research.
Human and animals rights
All manuscripts concerning clinical investigations with humans or human materials must have been performed in accordance with the Declaration of Helsinki and should include a statement confirming that all subject or subject’s guardian provided written consent before participation after adequate explanation. Also, all studies must include a statement that the project was approved by the local Ethical Committee. Any reasons for waiving to obtain informed consent must be clearly declared. All manuscripts reporting the results of experimental investigations involving animals are required to give assurance statement that the animals were cared for in accordance with a standard guide to the care and use of experimental animals and must include a statement that the that their use of animals and experiments was reviewed and approved by the local Ethical Committee.